NCT01671059View on ClinicalTrials.gov

A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Rheumatoid Arthritis
Trial Locations (8)

11000

Institut Za Reumatologiju; Reumatologiju, Belgrade

Military Medical Academy; Clinic of Rheumatology, Belgrade

Belgrade

18205

Institute of Rheumatology and Cardiovascular Diseases; Rheumatology, Niška Banja

Niška Banja

21000

Clinical Center Voivodina; Clinic for Immunology and Nephrology, Novi Sad

Special hospital for rheumatic diseases Novi Sad, Novi Sad

Novi Sad

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01671059 - A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra) | Biotech Hunter | Biotech Hunter